Apnimed's experimental drug reduced breathing interruptions by nearly 46.8% in clinical trials, offering a potential ...

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

Comedian and Emmy-nominated actor Kym Whitley opens up about her long journey with weight management. The "Happy Gilmore 2" ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there? Here's what to know.

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

The two drugs have a different set of broader indications, with Zepbound also approved to treat sleep apnea in people with obesity, for example.

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...